Global Biotechnology Market


Posted November 20, 2014 by Alinajohn

Biotechnology is an innovative science in which living systems and organisms are used to develop new and useful products, ranging from healthcare products to seeds.

 
According to the United Nations’ Convention on Biological Diversity, biotechnology is defined as, ‘any technological application which uses biological systems, living organism or its derivatives, used to create or modify products and processes for specific purpose.
Browse Report : http://www.transparencymarketresearch.com/biotechnology-market.html
The biotechnology market is expected to show substantial growth during the forecast period from 2012 to 2017, owing to regulatory support offered to various companies operating in the biotechnology field. In addition, increased demand for food in developing countries has spurred the growth of the bioagriculture market. Bioseeds are expected to show exponential growth compared to conventional seeds during the forecast period from 2012 to 2017.

This report on the biotechnology market analyzes and estimates the global revenue (in terms of USD million) generated by the biotechnology industry over the forecast period i.e. from 2012 to 2017. The biotechnology market has been segmented on the basis of technology and application. On the basis of applications, biotechnology market is divided into four primary segments, namely; biopharmacy, bioservices, bioagriculture and bioindustrial. In terms of technology, the biotechnology market has been segmented into fermentation, tissue regeneration, PCR technology, nanobiotechnology, chromatography, DNA sequencing, cell based assay and others. The others segment comprises genetic engineering, enzyme technology and fingerprinting among others.

Biopharmacy comprises various pharmaceuticals manufactured by using biotechnology and also covers medical devices. The bioservices segment predominantly consists of CROs (Contract Research Organizations) which are third party organizations performing clinical trials, drug discovery and contract manufacturing. The bioindustrial application includes the use of bioenzymes and biochemicals for a variety of chemical processes. Bioagriculture comprises bioseeds and genetically modified (GM) crops. The market of these segments has been extensively analyzed on the basis of various factors that drives and restrains the growth of each segment. The market size is expressed in terms of value in USD million.

Further, the biotechnology market is also segmented on the basis of geography, such as, North America, Europe, Asia-Pacific and Rest of the World (RoW). North America was the largest biotechnology market in 2011 and is expected to retain its leadership throughout the forecast period from 2012 to 2017. This leadership was achieved due to high adoption of biopharmaceuticals and increased preference towards bioservices.

The market overview section of the report explains various drivers and restraints affecting the market along with the impact they would have during the forecast period. A detailed analysis of the opportunities available in the market over the next five years has also been included. The value chain analysis for the biotechnology market has been provided for a better understanding of the process followed in the market. The study covers in detail the Porter’s five forces analysis, which gives the users of this report a better perspective into the present and future market scenarios. The market share analysis section of the report provides the state of competition amongst the key players operating in the market. These various analyses, altogether, would help the user of this report to understand the market more thoroughly.

In addition, key market players have been profiled with respect to attributes such as company overview, financial overview, SWOT analysis, business strategy and recent developments. Key market players that are profiled in the report include Abbott Laboratories, Inc., Amgen, Inc., AstraZeneca plc, Biogen Idec Inc., Celgene Corporation, F. Hoffman La Roche Ltd, Genentech Inc., Genzyme Corporation, Gilead Sciences, GlaxoSmithKline plc, Johnson & Johnson, Lonza Group Ltd., Merck & Co., Inc., Novartis International AG, Novo Nordisk A/S, Pfizer, Inc. and Sanofi. A detailed company market share has been included to give a better understanding of the competitive situation in the market.

Request a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=498

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Alina
Website http://www.transparencymarketresearch.com/biotechnology-market.html
Phone 15186181030
Business Address 90 State Street,
Suite 700
Country United States
Categories Biotech , Business
Tags global biotechnology market
Last Updated November 20, 2014